2 questions sent by me. Let's see if we get any details on the below
1. There seems to be a lot of concern in several countries about “The overprescribing of antibiotics”. A number of these are establishing grants and programs to address this huge issue. Is Lumos involved in any talks or tenders in providing support to these programs? Or have you been approached with inquiries? If not, are you seeking opportunities in this area?
2. You have said in the past you will match production in line with sales to avoid past stocking issues. What is the production capacity currently? Are you making plans to increase production based on the interest received?
GLTAH
Ann: Commercial Operations Update Webinar Presentation, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $37.38K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 337500 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 942945 | 1 |
View Market Depth
| Last trade - 15.55pm 23/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |